Zhang Hongbo, Yin Xifan, Ouyang Zhiyuan, Chen Jing, Zhou Shenghua, Zhang Changguo, Pan Xin, Wang Shiliang, Yang Junxiang, Feng Yaoyao, Yu Ping, Zhang Qiangchun
aDepartment of Neurology bDepartment of Psychiatry, Third People's Hospital of Huzhou cDepartment of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Province, China.
Medicine (Baltimore). 2016 Jun;95(26):e4056. doi: 10.1097/MD.0000000000004056.
This study investigated the risk factors for freezing of gait (FOG) in the early stage of Parkinson disease in China, using a sample of 248 patients who were followed for 3 years. Part III of the Unified Parkinson Disease Rating Scale and the modified Hoehn-Yahr grading scale were used to evaluate the severity of motor symptoms. Nonmotor symptoms were assessed using the Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale (HAMD), and Non-Motor Symptoms Scale (NMSS). The end-point was the presence of FOG at the end of follow-up; patients with FOG were classified as freezers. The risk factors for FOG were analyzed at the end of the first, second, and third years after baseline. There were 40 freezers (16.13%) 1 year later, 98 (39.52%) 2 years later, and 128 (51.61%) 3 years later. FOG 3 years later was associated with the following variables: depression (P = 0.003), older age, living in the countryside, lower education, akinetic-rigid style, lower limbs as site of onset, early use of levodopa, higher daily dose of levodopa, and not using amantadine or selegiline and dopamine receptor agonists (P < 0.001). Early use of amantadine, selegiline, and dopamine receptor agonists was negatively related to FOG (P < 0.001). Binary logistic regression found that FOG was associated with lower education (odds ratio [OR] = 0.012, P < 0.001), akinetic-rigid style (OR = 4.881, P = 0.024), not using dopamine receptor agonists (OR = 4.324, P = 0.035), cognitive disturbances (OR = 0.331, P = 0.007), and sleep disorders (OR = 2.418, P = 0.036). However, the cardiovascular domain of the NMSS (OR = 2.729, P = 0.001) was the only risk factor for FOG 1 year later. Two years later, FOG was associated with mixed style (OR = 0.189, P = 0.005), lower limbs as site of onset (OR = 4.772, P = 0.008), not using dopamine receptor agonists (OR = 0.031, P < 0.001), and the anxiety/somatic domain of the HAMD (OR = 0.596, P = 0.033). Scores at baseline, patients with Parkinson disease were more likely to experience FOG if: they were older, or from the countryside; had an akinetic-rigid style, anxiety, or higher NMSS scores; they used levodopa early or did not use amantadine or selegiline; their lower limbs were the site of onset; or they had more severe motor disability or higher HAMD scores at baseline.
本研究以248例随访3年的中国帕金森病早期患者为样本,调查了步态冻结(FOG)的危险因素。采用统一帕金森病评定量表第三部分和改良的 Hoehn-Yahr 分级量表评估运动症状的严重程度。使用汉密尔顿焦虑评定量表、汉密尔顿抑郁评定量表(HAMD)和非运动症状量表(NMSS)评估非运动症状。终点为随访结束时是否存在FOG;有FOG的患者被归类为冻结者。在基线后的第一、第二和第三年末分析FOG的危险因素。1年后有40例冻结者(16.13%),2年后有98例(39.52%),3年后有128例(51.61%)。3年后的FOG与以下变量相关:抑郁(P = 0.003)、年龄较大、居住在农村、受教育程度较低、运动不能-强直型、下肢为发病部位、早期使用左旋多巴、左旋多巴每日剂量较高,以及未使用金刚烷胺、司来吉兰和多巴胺受体激动剂(P < 0.001)。早期使用金刚烷胺、司来吉兰和多巴胺受体激动剂与FOG呈负相关(P < 0.001)。二元逻辑回归发现,FOG与受教育程度较低(比值比[OR]=0.012,P < 0.001)、运动不能-强直型(OR = 4.881,P = 0.024)、未使用多巴胺受体激动剂(OR = 4.324,P = 0.035)、认知障碍(OR = 0.331,P = 0.007)和睡眠障碍(OR = 2.418,P = 0.036)有关。然而,NMSS的心血管领域(OR = 2.729,P = 0.001)是1年后FOG的唯一危险因素。2年后,FOG与混合型(OR = 0.189,P = 0.005)、下肢为发病部位(OR = 4.772,P = 0.008)、未使用多巴胺受体激动剂(OR = 0.031,P < 0.001)以及HAMD的焦虑/躯体领域(OR = 0.596,P = 0.033)有关。在基线时,如果帕金森病患者年龄较大或来自农村;具有运动不能-强直型、焦虑或NMSS得分较高;早期使用左旋多巴或未使用金刚烷胺或司来吉兰;下肢为发病部位;或在基线时运动残疾更严重或HAMD得分较高,则更有可能出现FOG。